Don Weissman, MD

Life Sciences and Healthcare


KOL Relationships, Identification, Governance

Senior Medical Science Liaison


Strategic Marketing and Communications

 Business Development
 Better Outcomes and Quality of Life

Biopharmaceuticals, Technologies, Devices, AI 

Genetics, Telehealth, SM, HEOR and Services

 Initiatives, Alliances, Partnerships 
   

 

"A MISSION OF BETTER HEALTH, LONGEVITY and QUALITY OF LIFE

 

Strategic Business Development

 Communications and Commercial Optimization  

Senior Medical Science Liaison 

   KOL Relationships and Governance.

  

   Biotech-Pharmaceuticals, Devices, Technologies,

Diagnostics, AI, Genetics, Trials and Services.


KOL, HCP and C suite relationships, 

 identification and development 

  LifeSciences and Healthcare, 

Academic, Corporate and Clinical. 


Proven track record helping Life Science Companies, 

 KOLs, entrepreneurs, clinicians, scientists

& Healthcare Institutions accelerate clinical and

commercial development,

optimize market share and success for patient benefits,

better outcomes and quality of life, 

caretaker, provider and stakeholder values. 

 

Exceptional education, success and experience,

 relationships, communications and interpersonal skills to

build and generate professional consensus.


Key Opinion Leader insights, 

 scientific exchange and rapport for 

trials, analytics, compliance,

 applications, adoption and advocacy.


Advisory Board Development, Honored Society

 and Board Relationships with Subject Matter Experts,

 Academic & University Medical Centers, 

Physicians of Influence and Healthcare Decision Makers.

 

Analyst, grant review and panel member for the

 National Science Foundation, the NSF. 
the National Institute of Health, the NIH and 

Department of Health & Human Services, the HHS.

 Biotech & medical treatments, diagnostics, genomics

bio-pharmaceuticals, devices and therapeutics.


Adept listener, articulate and persuasive, 
building professional consensus for better outcomes,
trials, applications, approvals, and advocacy,
greater compliance and adherence, accelerating
the needs, drivers and implementations for success. 
 
In-depth Physician, KOL, HCP & Patient Education.
Pharmaco-economics, HEOR and Vigilance for resource
allocation & adoptionHighly successful with the FDA, FTC,
PhRMA, AHRQ and CMS. Proven track record of success for coverage
and reimbursements by government, insurance, payers and plans.
 

Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, communications,

 brand and market development, mobile and social media
applications with validation. 

 

Extraordinary resources, knowledge and success

developing and strengthening internal and external 

partnerships and alliances with renowned KOL's, academic, 

 corporate, government and clinical leaders.

 


GOALS:

 

                

Better therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


To optimize patient well being, quality of life, caretaker,

provider and stakeholder values


 Excellence
in clinical, operational and economic outcomes.